Febbo Phillip G.'s Form 4 filing
Veracyte, Inc. (VCYT) · filed Oct 7, 2025
- Accession no.
- 0001649245-25-000005
- Filed
- Oct 7, 2025
- Trade date
- Oct 6, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $300.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Febbo Phillip G.CIK 0001649245 | Officer (Chief Scientific & Med Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | SSaleDisposed | −8,349 | $36.02F2 | −$300,730.98 | 92,441 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents weighted average sales price. Sale prices for the transactions range from $35.82 to $36.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.